ABSTRACT
BACKGROUND: Extracellular matrix (ECM) proteases play a key role in the regulation of tumour invasion, growth, and transendothelial migration. The expression of ECM proteases and their endogenous inhibitors by cancer cells is regulated by stromal cells. We investigated the effect of commonly used perioperative medications on this regulation. METHODS: Breast cancer cells (4T1) were cultured alone or with endothelial cells (H5V) or macrophages (RAW264.7). Cell grown alone or in cocultures were treated with clinically relevant concentrations of cyclooxygenase (COX) inhibitors, aspirin (ASA), ketorolac, celecoxib, or lysine antifibrinolytics, É-aminocaproic acid (EACA) and tranexamic acid (TXA). We determined the level of the ECM proteases urokinase-like plasminogen activator (uPA), matrix metalloproteinase (MMP)-2 and MMP-9, and endogenous MMP inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in the conditioned media. RESULTS: Antifibrinolytics and COX inhibitors exerted a complex effect on cells grown alone and in cocultures. EACA increased the activity of MMP-9 and TIMP-1 in cocultures of 4T1 and RAW264.7. TXA increased TIMP-1 in the coculture without affecting MMP-9. EACA and TXA both attenuated MMP-2 detected in 4T1 and H5V cocultures. ASA and ketorolac both decreased the activity of MMP-2, MMP-9, and uPA. Celecoxib increased the activity of TIMP-1 in cocultures of 4T1 with both macrophages and endothelial cells. CONCLUSIONS: Antifibrinolytics and COX inhibitors can affect the proteolytic profile of the tumour microenvironment. Animal and clinical investigations are warranted to assess the effect of these proteolytic changes on the outcome of cancer surgery.
Subject(s)
Antifibrinolytic Agents/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Endothelial Cells/physiology , Macrophages/physiology , Mammary Neoplasms, Experimental/pathology , Animals , Cell Communication/drug effects , Cell Communication/physiology , Coculture Techniques , Culture Media, Conditioned , Extracellular Matrix/drug effects , Extracellular Matrix/enzymology , Female , Mammary Neoplasms, Experimental/metabolism , Mice , Peptide Hydrolases/metabolism , Protease Inhibitors/pharmacology , Proteolysis/drug effects , Tumor Cells, Cultured , Tumor Microenvironment/drug effects , Tumor Microenvironment/physiologySubject(s)
Anesthesia/methods , Anesthesiology/methods , Neoplasms/surgery , Periodicals as Topic , Humans , United KingdomABSTRACT
UNLABELLED: The effect of opioids on tumour growth and metastasis has been debated for many years, with recent emphasis on the possibility that they might influence the rate of disease-free survival after tumour resection when used in the perioperative pain management of cancer surgery patients. The literature presents conflicting and inconclusive in vitro and in vivo data about the potential effect of opioids, especially morphine, on tumour growth and metastasis. To inform clinical practice, appropriate animal models are needed to test whether opioids alter the course of tumour growth and metastasis. Here, we review the literature on animal-based studies testing the effect of morphine on cancer so far, and analyse differences between the models used that may explain the discrepancies in published results. Such analysis should elucidate the role of opioids in cancer and help define ideal pre-clinical models to provide definitive answers. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
Subject(s)
Morphine/therapeutic use , Neoplasm Metastasis , Neoplasms/drug therapy , Animals , Disease Models, Animal , Drug Administration Routes , Humans , Morphine/administration & dosage , Morphine/pharmacology , Neoplasm Metastasis/pathology , Neoplasms/pathology , Neoplasms/surgery , Pain/drug therapy , Pain/prevention & control , Perioperative Period , Receptors, Opioid/metabolismABSTRACT
Reactive oxygen species (ROS) are involved in the mechanism of photoaging and carcinogenesis. Skin is endowed with antioxidant enzymes including superoxide dismutases (SOD): cytosolic copper zinc SOD and mitochondrial manganese SOD. The aim of our study was to estimate the protective effect of manganese against oxidative injury on cultured human skin fibroblasts. Dithranol, hydrogen peroxide and UV-A radiation (375 nm) were employed as oxidative stressors. The supply of manganese chloride produced an increase in cellular content of this element up to 24 fold without concomitant elevation of MnSOD activity. Nevertheless, manganese protects cells against two of the three ROS generating systems assessed, namely hydrogen peroxyde and UV-A. This protective effect depends on the concentration of manganese in the medium, 0.1 mM and 0.2 mM protect against UVA cytotoxicity, only 0.2 mM protects against H2O2 cytotoxicity.
Subject(s)
Manganese/pharmacology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Skin/metabolism , Anthralin , Cells, Cultured , Fibroblasts/metabolism , Humans , Hydrogen Peroxide , Ultraviolet RaysABSTRACT
Photodynamic-induced cytotoxicity by hypericin (HYP) was studied on three human melanoma cell lines: one pigmented cell line (G361) and two amelanotic cell lines (M18 and M6). No significant variation in the rate of uptake and in the maximum level of HYP incorporation for the different cells was observed. In the dark, no cytotoxicity was observed in the range 0-10-6 M HYP for the three cell lines. Amelanotic cells were found to be more sensitive than pigmented cells to irradiation of HYP with visible light (lambda > 590 nm). In addition, for the three cell lines HYP-induced photocytotoxicity was found to be drug-dose and light-dose dependent. Under the conditions used, thiobarbituric acid-reacting substances (TBARs) were significantly increased in amelanotic cells after irradiation (P < 0.0001). By contrast, the amount of TBARS remained unchanged in pigmented cells. Antioxidant defenses including enzymes and glutathione (GSH) were assayed before and after HYP photosensitization. Significantly increased total SOD activity was observed after photosensitizaton for amelanotic cells (P < 0.05), while glutathione peroxidase (GSHPx) and catalase (Cat) activities but also GSH levels were significantly decreased (P < 0.01). In pigmented cells a significantly increased Cat activity was found (P < 0.05), whereas GSHPx was unaffected after irradiation. It can be inferred that (a) HYP may be an effective PDT agent for melanoma and (b) there is a relationship between melanin content and sensitivity to HYP phototoxicity in human melanoma cells.
Subject(s)
Lipid Peroxidation/drug effects , Melanoma/drug therapy , Melanoma/metabolism , Perylene/analogs & derivatives , Photochemotherapy , Radiation-Sensitizing Agents/pharmacology , Anthracenes , Humans , Perylene/pharmacokinetics , Perylene/pharmacology , Radiation-Sensitizing Agents/pharmacokinetics , Tumor Cells, CulturedABSTRACT
Zinc has been shown to have antioxidant properties and to exhibit inhibitory effects on apoptosis. In this work we investigated the effect of zinc on DNA integrity and on apoptosis of HaCaT keratinocytes. Cells were submitted to zinc deprivation by a diffusible zinc chelator, (N,N,N',N'-tetrakis (2-pyridylmethyl)ethylenediamine) (TPEN) or supplied with zinc chloride and submitted to UVB radiation. After cell exposure to TPEN for 2 h, strand breaks significantly impaired DNA resistance to alkaline denaturation. DNA strand breaks induced by a 6 h TPEN application were significantly prevented if zinc chloride was supplied together with the chelator. TPEN also generated, after 4-6 h of application, cytoplasmic histone-associated DNA fragments (mononucleosomes and oligonucleosomes), features of cell death by apoptosis. Moreover, UVB irradiation led to early DNA strand breaks and to an increase in cytoplasmic nucleosomes which was maximum 10 h after irradiation. These effects were prevented by the supply of zinc chloride (0.1 mM) in the culture medium. These results suggest that zinc ions interfere with the apoptosis process at an early stage, by decreasing DNA damage able to trigger apoptosis.
Subject(s)
Apoptosis , DNA Fragmentation , Keratinocytes/cytology , Ultraviolet Rays , Zinc/physiology , Apoptosis/drug effects , Apoptosis/radiation effects , Chelating Agents/pharmacology , DNA Fragmentation/radiation effects , Ethylenediamines/pharmacology , HumansABSTRACT
The possible application of hypericin (hyp) in the photodynamic therapy (PDT) of cancer was investigated using the human fibroblast cell line MRC5. In aerobic conditions, at pH 7.4, irradiation of MRC5 cells was carried out with different doses of visible light and different doses of hyp. A low concentration of hyp (5 x 10(-9) M) was highly toxic to MRC5 cells, producing 15% survival for an irradiation period of 40 min. In the dark, no cytotoxicity was observed in the range 10(-9)-10(-7) M hyp. The mechanism of cell killing by hyp was also examined. Significant inhibition of MRC5 killing was observed on addition of 1,4-diazabicyclo[2,2,2]octane (DABCO) or histidine, known quenchers of type II mechanisms. In addition, the photodynamic effect of hyp was enhanced by deuterium oxide. The addition of desferrioxamine, catalase or superoxide dismutase (SOD), known scavenging agents of the type I mechanism, had a significant inhibitory effect on the rate of photodynamic action of hyp. The experimental results suggest that hyp has considerable potential for use as a sensitizer in the PDT of cancer.
Subject(s)
Cell Survival/drug effects , Perylene/analogs & derivatives , Radiation-Sensitizing Agents/toxicity , Anthracenes , Catalase/pharmacology , Cell Line , Cell Survival/radiation effects , Darkness , Deferoxamine/pharmacology , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Fibroblasts/drug effects , Fibroblasts/radiation effects , Histidine/pharmacology , Humans , Kinetics , Light , Perylene/toxicity , Photochemotherapy , Piperazines/pharmacology , Radiation-Protective Agents/pharmacology , Superoxide Dismutase/pharmacology , Time FactorsABSTRACT
The effect of zinc (Zn) on cellular oxidative metabolism is complex and could be explained by multiple complementary interactions. In this study, we evaluated the impact of Zn on the pro-oxidant/antioxidant balance of HaCaT keratinocytes. Cells were submitted to a diffusible metal chelator able to induce intracellular Zn deprivation, TPEN, in combination or not with Zn chloride (ZnCl2), in the culture medium. The intracellular amount of Zn, copper (Cu), and iron (Fe) was determined, as well as CuZnSOD and MnSOD activities and glutathione reserves. The consequence of the modulation of Zn concentration on lipid peroxidation was also evaluated. TPEN induced a significant dose-dependent decrease in intracellular Zn and Cu (from 394-181 and 43-21 microg/g protein, respectively, after 6 h of TPEN 50 microM). No significant change in intracellular Fe concentration was found following TPEN exposure. The SOD activities were unchanged after 6 h of TPEN 50 microM application, either CuZnSOD or MnSOD. Cells exposure to TPEN induced a deep time- and dose-dependent decrease in their glutathione content (from 65-8 microM/g protein after 6 h of TPEN 50 microM), and a concomitant increase in glutathione in the cell-culture supernatants. No significant change in lipid peroxidation products was detected.
Subject(s)
Antioxidants/metabolism , Chelating Agents/pharmacology , Ethylenediamines/pharmacology , Keratinocytes/drug effects , Keratinocytes/metabolism , Oxidants/metabolism , Zinc/metabolism , Cell Line , Chlorides/pharmacology , Copper/analysis , Copper/metabolism , Culture Media , Diffusion , Dose-Response Relationship, Drug , Glutathione/metabolism , Humans , Iron/analysis , Iron/metabolism , Keratinocytes/cytology , Lipid Peroxidation/drug effects , Superoxide Dismutase/analysis , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/analysis , Zinc/analysis , Zinc Compounds/pharmacologyABSTRACT
Heat shock protein (HSP) synthesis results from various types of injury, including heat shock (HS) and some oxidants. The intracellular signals leading to HSP synthesis are not yet fully elucidated. We have studied the influence of NNN'N'-tetrakis(2-pyridylmethyl)ethylene diamine (TPEN), a metal chelator known to induce cellular zinc and copper deprivation, on resistance to heat and on hsp70 synthesis in HaCaT keratinocytes. TPEN was shown to sensitize HaCaT cells to heat shock. The effect of TPEN was neutralized by equimolar Zn2+. By the use of sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis and Western blotting characterization of hsp70, it was shown that cultured HaCaT cells constitutively express the inducible form of hsp70. The application of TPEN alone slightly increases the level of hsp70 but inhibits its induction by HS. This inhibitory effect is related to metal deprivation, because it is eliminated when Cu2+ or Zn2+ ions are supplied together with TPEN. These results suggest that these metals are involved in the expression by keratinocytes of a stress protein which has a protective action against environmental stress.
Subject(s)
Chelating Agents/pharmacology , Ethylenediamines/pharmacology , HSP70 Heat-Shock Proteins/biosynthesis , Keratinocytes/drug effects , Keratinocytes/metabolism , Cell Survival/drug effects , Cells, Cultured/drug effects , Cells, Cultured/metabolism , HSP70 Heat-Shock Proteins/drug effects , Hot Temperature , Humans , Keratinocytes/cytologyABSTRACT
Metallothioneins (MT) are a family of intracellular, cysteine-rich, zinc-binding proteins. Their expression is constitutive but can also be induced at the transcriptional level by various stimuli. In this study, we exposed HaCaT human keratinocytes to excess zinc (ZnCl2) or to zinc deprivation by the diffusible chelator NNN'N'-tetrakis(2-pyridylmethyl)ethylene diamine (TPEN), and to ultraviolet B (UVB) irradiation. We examined both cell proliferation and MT expression. Cell proliferation was maximally stimulated by 100 microM Zn2+ supply and was markedly inhibited by zinc deprivation or UVB irradiation. Zinc and UVB irradiation both increased MTI and/or MTII as detected by immunocytochemistry and enhanced the baseline level of MT-IIA mRNA, whereas TPEN treatment inhibited MT basal expression. Zinc partially prevented the concentration-dependent, UVB-induced decrease in cell proliferation. On the other hand, TPEN partially prevented the UVB-induced increase in MTIIA mRNA. These results suggest that zinc is involved in defense mechanisms of skin keratinocytes and in their stress-induced response.
Subject(s)
Cell Division/drug effects , Chelating Agents/pharmacology , Ethylenediamines/pharmacology , Metallothionein/genetics , Blotting, Northern , Cell Line, Transformed , Gene Expression Regulation/drug effects , Gene Expression Regulation/radiation effects , Humans , Immunohistochemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ultraviolet Rays , Zinc/pharmacologyABSTRACT
Caveolin-1 is a palmitoylated protein involved in assembly of signaling molecules in plasma membrane subdomains termed caveolae and in intracellular cholesterol transport. Three cysteine residues in the C terminus of caveolin-1 are subject to palmitoylation, which is not necessary for caveolar targeting of caveolin-1. Protein palmitoylation is a post-translational and reversible modification that may be regulated and that in turn may regulate conformation, membrane association, protein-protein interactions, and intracellular localization of the target protein. We have undertaken a detailed analysis of [(3)H]palmitate incorporation into caveolin-1 in aortic endothelial cells. The linkage of palmitate to caveolin-1 was hydroxylamine-sensitive and thus presumably a thioester bond. However, contrary to expectations, palmitate incorporation was blocked completely by the protein synthesis inhibitors cycloheximide and puromycin. In parallel experiments to show specificity, palmitoylation of aortic endothelial cell-specific nitric-oxide synthase was unaffected by these reagents. Inhibitors of protein trafficking, brefeldin A and monensin, blocked caveolin-1 palmitoylation, indicating that the modification was not cotranslational but rather required caveolin-1 transport from the endoplasmic reticulum and Golgi to the plasma membrane. In addition, immunophilin chaperones that form complexes with caveolin-1, i.e. FK506-binding protein 52, cyclophilin A, and cyclophilin 40, were not necessary for caveolin-1 palmitoylation because agents that bind immunophilins did not inhibit palmitoylation. Pulse-chase experiments showed that caveolin-1 palmitoylation is essentially irreversible because the release of [(3)H]palmitate was not significant even after 24 h. These results show that [(3)H]palmitate incorporation is limited to newly synthesized caveolin-1, not because incorporation only occurs during synthesis but because the continuous presence of palmitate on caveolin-1 prevents subsequent repalmitoylation.
Subject(s)
Caveolins/metabolism , Cyclophilins , Endothelium, Vascular/metabolism , Palmitic Acid/metabolism , Protein Processing, Post-Translational , Animals , Aorta , Brefeldin A/pharmacology , Carrier Proteins/metabolism , Cattle , Caveolin 1 , Cells, Cultured , Cycloheximide/pharmacology , Cyclophilin A/metabolism , Peptidyl-Prolyl Isomerase F , Hydroxylamine/pharmacology , Methionine/metabolism , Peptidylprolyl Isomerase/metabolism , Protein Synthesis Inhibitors/pharmacology , Tacrolimus Binding Proteins/metabolismABSTRACT
The transcription factor p53 controls the proliferation and survival of cells exposed to DNA damage. The specific DNA-binding domain of p53 (residues 102-292) has a complex tertiary structure that is stabilized by zinc. In this study, we showed that exposure of cultured cells to the membrane-permeable chelator N,N,N', N'-tetrakis(2-pyridylmethyl)ethylenediamine induced wild-type p53 to accumulate in an immunologically "mutant" form (PAb240+, PAb1620-) with decreased DNA-binding activity. Removal of N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine from culture medium allowed p53 to refold into the immunologically wild-type form, followed by a transient increase in DNA binding, expression of the cyclin-dependent kinase inhibitor p21WAF1, and cell-cycle delay in the G1 phase. Thus, modulation of intracellular zinc induced conformational changes in p53 that activated wild-type function, suggesting that metalloregulation may play a role in controlling p53.